BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16258703)

  • 1. Adaptation of estrogen-regulated genes in long-term estradiol deprived MCF-7 breast cancer cells.
    Santen RJ; Lobenhofer EK; Afshari CA; Bao Y; Song RX
    Breast Cancer Res Treat; 2005 Dec; 94(3):213-23. PubMed ID: 16258703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.
    Pennanen PT; Sarvilinna NS; Ylikomi TJ
    Anticancer Drugs; 2009 Jan; 20(1):51-8. PubMed ID: 19343000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach.
    Itoh T; Karlsberg K; Kijima I; Yuan YC; Smith D; Ye J; Chen S
    Mol Cancer Res; 2005 Apr; 3(4):203-18. PubMed ID: 15831674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase inhibitors: rationale for use following antiestrogen therapy.
    Yue W; Santen RJ
    Semin Oncol; 1996 Aug; 23(4 Suppl 9):21-7. PubMed ID: 8824461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells.
    Berstein LM; Yue W; Wang JP; Santen RJ
    Breast Cancer Res Treat; 2011 Jul; 128(1):109-17. PubMed ID: 20683653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.
    Jeng MH; Shupnik MA; Bender TP; Westin EH; Bandyopadhyay D; Kumar R; Masamura S; Santen RJ
    Endocrinology; 1998 Oct; 139(10):4164-74. PubMed ID: 9751496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of VDR-responsive gene signatures in breast cancer cells.
    Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
    Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment.
    Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura S; Lawrence J; MacMahon LP; Yue W; Berstein L
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):155-65. PubMed ID: 16024245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Syed V; Zhang X; Lau KM; Cheng R; Mukherjee K; Ho SM
    Oncogene; 2005 Dec; 24(55):8128-43. PubMed ID: 16116479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines.
    Vendrell JA; Bieche I; Desmetz C; Badia E; Tozlu S; Nguyen C; Nicolas JC; Lidereau R; Cohen PA
    Endocr Relat Cancer; 2005 Mar; 12(1):75-92. PubMed ID: 15788640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
    Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
    Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines.
    Ramachandran C; Rodriguez S; Ramachandran R; Raveendran Nair PK; Fonseca H; Khatib Z; Escalon E; Melnick SJ
    Anticancer Res; 2005; 25(5):3293-302. PubMed ID: 16101141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal.
    Lewis JS; Osipo C; Meeke K; Jordan VC
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):131-41. PubMed ID: 15862958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of Bcl-2 enhances estrogen apoptotic action in long-term estradiol-depleted ER(+) breast cancer cells.
    Song RX; Zhang Z; Mor G; Santen RJ
    Apoptosis; 2005 May; 10(3):667-78. PubMed ID: 15909128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
    Perera CN; Chin HG; Duru N; Camarillo IG
    J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-type-specific responses to chemotherapeutics in breast cancer.
    Troester MA; Hoadley KA; Sørlie T; Herbert BS; Børresen-Dale AL; Lønning PE; Shay JW; Kaufmann WK; Perou CM
    Cancer Res; 2004 Jun; 64(12):4218-26. PubMed ID: 15205334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells.
    Fotovati A; Fujii T; Yamaguchi M; Kage M; Shirouzu K; Oie S; Basaki Y; Ono M; Yamana H; Kuwano M
    Clin Cancer Res; 2006 May; 12(10):3010-8. PubMed ID: 16707596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.
    Cappelletti V; Gariboldi M; De Cecco L; Toffanin S; Reid JF; Lusa L; Bajetta E; Celio L; Greco M; Fabbri A; Pierotti MA; Daidone MG
    Endocr Relat Cancer; 2008 Jun; 15(2):439-49. PubMed ID: 18508997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration-dependent effects of genistein on global gene expression in MCF-7 breast cancer cells: an oligo microarray study.
    Lavigne JA; Takahashi Y; Chandramouli GV; Liu H; Perkins SN; Hursting SD; Wang TT
    Breast Cancer Res Treat; 2008 Jul; 110(1):85-98. PubMed ID: 17687646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
    Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.